Multiple myeloma is a type of cancer characterized by the uncontrolled proliferation of clonal plasma cells, which leads to organ dysfunction and, eventually, death. There were more than 33,000 ...
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced its 2024 Annual Results. Business Highlights Zevor-cel was ...
Biogen Inc. ( NASDAQ: BIIB) Stifel 2025 Virtual CNS Forum Conference March 18, 2025 10:15 AM ET Great. Good morning, everybody. Happy to be moderating my annual panel where Priya has to listen to me ...
Darzalex and Revlimid maintenance resulted in superior outcomes versus Revlimid alone following autologous stem cell ...
Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...
Clinical Trials Arena on MSN14h
Orca Bio makes a splash as T-cell therapy cuts GvHD in blood cancer patientsGraft versus host disease (GvHD) is a complication from stem cell transplants where the patient recognises the cells as ...
News-Medical.Net on MSN16h
In the Thymus We Trust: ProTcell Therapy & the Future of Allogeneic ImmunotherapyIn this interview, News Medical speaks with Olivier Negre, Chief Scientific Officer at Smart Immune, about how immunotherapy is being revolutionized.
Tech Xplore on MSN11h
T-38 Talon jets receive help addressing critical aging aircraft issue causing cracksSouthwest Research Institute (SwRI) collaborated with the U.S. Air Force to ensure fleet safety after a large crack was ...
A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback